Here are the 10-Q quarterly reports from Runway Growth Finance Corp. 7.25% Notes due 2031 (RWAYI) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow RWAYI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RWAYI filings page.
RWAY presents a detailed schedule of control and non-control investments across sectors such as health care equipment and services, pharmaceuticals and biotechnology, application software, technology hardware, financial services, consumer staples distribution and retail, commercial and professional services, media and entertainment, and insurance.
The portfolio includes many senior secured debt positions that reference SOFR or Prime plus a spread, with contractual rate floors and features such as PIK and ETP components; examples include loans to 4Web, Inc. at SOFR+9.25% with a 12.75% floor and 34.43% ETP, Biotricity, Inc. at SOFR+10.50% with an 11.50% floor and 10.29% ETP, and SPB C‑2024, LLC in Multi-Sector Holdings at fixed 15.00% PIK with 1.57% ETP. Alongside debt, RWAY holds numerous warrants, preferred and common equity stakes, and contractual rights such as success fees, royalties, contingent value rights, and earnouts, each with stated initial acquisition and maturity dates, with some instruments maturing as far out as 2035 and 2039.
Runway Growth Finance’s quarterly filing details a highly diversified investment portfolio made up of senior secured loans, preferred equity and warrants across software, healthcare, financial services, consumer and other sectors. Many debt positions are labeled senior secured with floating rates such as SOFR or PRIME plus sizable spreads, often with payment-in-kind (PIK) components and extra “ETP” return features, and maturities generally running from the mid‑2020s into the early 2030s.
The schedule also lists numerous warrant positions in common or preferred stock and several equity stakes, including control or significant interests in entities like Pivot3, Inc., Runway‑Cadma I LLC and Gynesonics, Inc. Overall, the table emphasizes broad sector exposure, frequent use of structured senior loans and long‑dated equity upside through warrants and preferred securities.